Daré Bioscience, Inc. (DARE)
NASDAQ: DARE · Real-Time Price · USD
2.710
-0.270 (-9.06%)
At close: Dec 20, 2024, 4:00 PM
2.660
-0.050 (-1.85%)
After-hours: Dec 20, 2024, 4:30 PM EST

Daré Bioscience Statistics

Total Valuation

DARE has a market cap or net worth of $23.58 million. The enterprise value is $18.24 million.

Market Cap 23.58M
Enterprise Value 18.24M

Important Dates

The last earnings date was Thursday, November 14, 2024, after market close.

Earnings Date Nov 14, 2024
Ex-Dividend Date n/a

Share Statistics

DARE has 8.70 million shares outstanding. The number of shares has increased by 16.28% in one year.

Current Share Class 8.70M
Shares Outstanding 8.70M
Shares Change (YoY) +16.28%
Shares Change (QoQ) +0.69%
Owned by Insiders (%) 1.59%
Owned by Institutions (%) 7.53%
Float 8.56M

Valuation Ratios

PE Ratio n/a
Forward PE n/a
PS Ratio 11.98
Forward PS 0.63
PB Ratio n/a
P/TBV Ratio n/a
P/FCF Ratio n/a
P/OCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings n/a
EV / Sales 9.69
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 1.14

Current Ratio 1.14
Quick Ratio 0.89
Debt / Equity n/a
Debt / EBITDA n/a
Debt / FCF n/a
Interest Coverage n/a

Financial Efficiency

Return on Equity (ROE) n/a
Return on Assets (ROA) -66.79%
Return on Capital (ROIC) -1,243.91%
Revenue Per Employee $72,358
Profits Per Employee -$138,645
Employee Count 26
Asset Turnover 0.09
Inventory Turnover n/a

Taxes

Income Tax n/a
Effective Tax Rate n/a

Stock Price Statistics

The stock price has decreased by -33.97% in the last 52 weeks. The beta is 1.27, so DARE's price volatility has been higher than the market average.

Beta (5Y) 1.27
52-Week Price Change -33.97%
50-Day Moving Average 3.53
200-Day Moving Average 4.07
Relative Strength Index (RSI) 30.51
Average Volume (20 Days) 59,893

Short Selling Information

The latest short interest is 55,786, so 0.64% of the outstanding shares have been sold short.

Short Interest 55,786
Short Previous Month 25,465
Short % of Shares Out 0.64%
Short % of Float 0.65%
Short Ratio (days to cover) 0.64

Income Statement

In the last 12 months, DARE had revenue of $1.88 million and -$3.60 million in losses. Loss per share was -$0.43.

Revenue 1.88M
Gross Profit -19.76M
Operating Income -23.03M
Pretax Income -28.87M
Net Income -3.60M
EBITDA -22.99M
EBIT -23.03M
Loss Per Share -$0.43
Full Income Statement

Balance Sheet

The company has $11.23 million in cash and $5.89 million in debt, giving a net cash position of $5.34 million or $0.61 per share.

Cash & Cash Equivalents 11.23M
Total Debt 5.89M
Net Cash 5.34M
Net Cash Per Share $0.61
Equity (Book Value) -1.48M
Book Value Per Share -0.17
Working Capital 1.79M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$8.01 million and capital expenditures -$617,528, giving a free cash flow of -$8.63 million.

Operating Cash Flow -8.01M
Capital Expenditures -617,528
Free Cash Flow -8.63M
FCF Per Share -$0.99
Full Cash Flow Statement

Margins

Gross Margin n/a
Operating Margin -1,224.40%
Pretax Margin -191.61%
Profit Margin -191.61%
EBITDA Margin n/a
EBIT Margin n/a
FCF Margin n/a

Dividends & Yields

DARE does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
Buyback Yield -16.28%
Shareholder Yield -16.28%
Earnings Yield -15.29%
FCF Yield -36.60%

Analyst Forecast

The average price target for DARE is $20.33, which is 650.19% higher than the current price. The consensus rating is "Strong Buy".

Price Target $20.33
Price Target Difference 650.19%
Analyst Consensus Strong Buy
Analyst Count 4
Revenue Growth Forecast (5Y) 134.46%
EPS Growth Forecast (5Y) n/a
Stock Forecasts

Stock Splits

The last stock split was on July 1, 2024. It was a reverse split with a ratio of 0.0833333:1.

Last Split Date Jul 1, 2024
Split Type Reverse
Split Ratio 0.0833333:1

Scores

DARE has an Altman Z-Score of -16.02 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score -16.02
Piotroski F-Score 3